Ascendis Pharma A/S Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used
Ascendis Pharma A/S (ASND) reported Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used of EUR 285.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-02-12.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed · last filed 2025-02-12
| Period end | Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used 12 month |
|---|---|
| 2024-12-31 | 285.00K EUR 20-F · filed 2025-02-12 |
| 2023-12-31 | 353.00K EUR 20-F · filed 2025-02-12 |
| 2022-12-31 | 280.00K EUR 20-F · filed 2025-02-12 |
| 2021-12-31 | 186.00K EUR 20-F · filed 2024-02-07 |
| 2020-12-31 | 470.00K EUR 20-F · filed 2023-02-16 |
| 2019-12-31 | 202.00K EUR 20-F · filed 2022-03-02 |